Inhibrx Biosciences received FDA acceptance for the biologics license application (BLA) of ozekibart targeting unresectable/metastatic chondrosarcoma, with a PDUFA date set for April 14, 2027. The company also reported positive interim data for ozekibart in colorectal cancer and strong phase 2 results for INBRX-106 combined with KEYTRUDA in head and neck cancer. These milestones highlight significant progress in their oncology pipeline. While the company has at least 12 months of cash runway, the high burn rate and upcoming clinical catalysts present both opportunities and risks for investors.
Inhibrx Biosciences news is presented with Pluang's health sector market data as of Sep 14, 2026 20:12 WIB: Among 91 priced health-sector US stocks tradable on Pluang, 53 rose and 28 fell today. Notable movers include TXG (10X Genomics Inc) at USD 67.01 with a 1-day change of -2.30%, BSX (Boston Scientific Corporation) at USD 43.94 with +2.23%, and AZN (AstraZeneca plc) at USD 163.72 with +2.22%.
Randstad reported revenue and earnings that exceeded expectations, driven by improving business trends and key labor markets. This positive performance signals momentum in the employment services sector. RBC Capital maintained a 'Sector Perform' rati...
MSC Industrial Supply reported strong Q4 results with revenue rising 10.3% year-over-year to about $1.08 billion, surpassing estimates. Adjusted earnings per share increased to $1.45 from $1.09, also beating expectations. Full-year sales grew 6.4% to...
ARMOUR Residential REIT reported a $327 million net loss for Q3 2026, driven by higher interest rates that reduced its book value by 17% to $14.55 per share. Despite the loss, the company earned $83.7 million in net interest income and $102.3 million...
Southern Company, an electric and gas utility, clarified it has no connection to a Mexican silver mining project, dispelling recent rumors. HSBC initiated coverage of Southern Company with a Buy rating, with shares trading at $90.39 at the time. The ...
Remittix is set to add 41 new fiat currencies to its PayFi ecosystem, enhancing crypto-to-bank and bank-to-crypto transactions globally ahead of its November 24 RTX launch. This expansion aims to support more international markets and users, includin...
